Preclinical Characterization of a Novel Anti-Cancer PD-L1 Inhibitor RPH-120

Overview of attention for article published in Frontiers in Pharmacology, August 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

ANTI-PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODY MOLECULES, ENCODING POLYNUCLEOTIDES, AND…

Application WO-2023159182-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.